Autonomix Medical, Inc. (AMIX)
(Delayed Data from NSDQ)
$1.29 USD
+0.10 (8.40%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $1.26 -0.03 (-2.33%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Autonomix Medical, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 9 | 1 | -99,999 | -99,999 | -99,999 |
Receivables | 0 | 0 | NA | NA | NA |
Notes Receivable | 0 | 0 | NA | NA | NA |
Inventories | 0 | 0 | NA | NA | NA |
Other Current Assets | 1 | 0 | NA | NA | NA |
Total Current Assets | 9 | 1 | NA | NA | NA |
Net Property & Equipment | 0 | 0 | NA | NA | NA |
Investments & Advances | 0 | 0 | NA | NA | NA |
Other Non-Current Assets | 0 | 0 | NA | NA | NA |
Deferred Charges | 0 | 0 | NA | NA | NA |
Intangibles | 0 | 0 | NA | NA | NA |
Deposits & Other Assets | 0 | 0 | NA | NA | NA |
Total Assets | 9 | 1 | NA | NA | NA |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | NA |
Accounts Payable | 0 | 0 | NA | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | NA |
Current Portion Capital Leases | 0 | 0 | NA | NA | NA |
Accrued Expenses | 0 | 0 | NA | NA | NA |
Income Taxes Payable | 0 | 0 | NA | NA | NA |
Other Current Liabilities | 0 | 0 | NA | NA | NA |
Total Current Liabilities | 1 | 0 | NA | NA | NA |
Mortgages | 0 | 0 | NA | NA | NA |
Deferred Taxes/Income | 0 | 0 | NA | NA | NA |
Convertible Debt | 0 | 0 | NA | NA | NA |
Long-Term Debt | 1 | 0 | NA | NA | NA |
Non-Current Capital Leases | 0 | 0 | NA | NA | NA |
Other Non-Current Liabilities | 0 | 0 | NA | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | NA |
Total Liabilities | 2 | 0 | NA | NA | NA |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | NA |
Common Stock (Par) | 0 | 0 | NA | NA | NA |
Capital Surplus | 47 | 24 | NA | NA | NA |
Retained Earnings | -39 | -24 | NA | NA | NA |
Other Equity | 0 | 0 | NA | NA | NA |
Treasury Stock | 0 | 0 | NA | NA | NA |
Total Shareholder's Equity | 8 | 1 | NA | NA | NA |
Total Liabilities & Shareholder's Equity | 9 | 1 | NA | NA | NA |
Total Common Equity | 8 | 1 | 0 | 0 | 0 |
Shares Outstanding | 18.70 | NA | NA | NA | NA |
Book Value Per Share | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Autonomix Medical, Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 9 | 1 | -99,999 | -99,999 |
Receivables | NA | 0 | 0 | NA | NA |
Notes Receivable | NA | 0 | 0 | NA | NA |
Inventories | NA | 0 | 0 | NA | NA |
Other Current Assets | NA | 1 | 0 | NA | NA |
Total Current Assets | NA | 9 | 2 | NA | NA |
Net Property & Equipment | NA | 0 | 0 | NA | NA |
Investments & Advances | NA | 0 | 0 | NA | NA |
Other Non-Current Assets | NA | 0 | 0 | NA | NA |
Deferred Charges | NA | 0 | 0 | NA | NA |
Intangibles | NA | 0 | 0 | NA | NA |
Deposits & Other Assets | NA | 0 | 0 | NA | NA |
Total Assets | NA | 9 | 2 | NA | NA |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | NA | NA |
Accounts Payable | NA | 0 | 1 | NA | NA |
Current Portion Long-Term Debt | NA | 0 | 0 | NA | NA |
Current Portion Capital Leases | NA | 0 | 0 | NA | NA |
Accrued Expenses | NA | 0 | 0 | NA | NA |
Income Taxes Payable | NA | 0 | 0 | NA | NA |
Other Current Liabilities | NA | 0 | 0 | NA | NA |
Total Current Liabilities | NA | 1 | 1 | NA | NA |
Mortgages | NA | 0 | 0 | NA | NA |
Deferred Taxes/Income | NA | 0 | 0 | NA | NA |
Convertible Debt | NA | 0 | 0 | NA | NA |
Long-Term Debt | NA | 1 | 1 | NA | NA |
Non-Current Capital Leases | NA | 0 | 0 | NA | NA |
Other Non-Current Liabilities | NA | 5 | NA | NA | |
Minority Interest (Liabilities) | NA | 0 | 0 | NA | NA |
Total Liabilities | NA | 2 | 7 | NA | NA |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | NA | NA |
Common Stock (Par) | NA | 0 | 0 | NA | NA |
Capital Surplus | NA | 47 | 28 | NA | NA |
Retained Earnings | NA | -39 | -34 | NA | NA |
Other Equity | NA | 0 | 0 | NA | NA |
Treasury Stock | NA | 0 | 0 | NA | NA |
Total Shareholder's Equity | NA | 8 | -6 | NA | NA |
Total Liabilities & Shareholder's Equity | NA | 9 | 2 | NA | NA |
Total Common Equity | 0 | 8 | -6 | 0 | 0 |
Shares Outstanding | 18.80 | 18.70 | 19.30 | NA | NA |
Book Value Per Share | 0.00 | 0.41 | -0.29 | 0.00 | 0.00 |